Literature DB >> 10626745

Flow cytometric detection of HLA antibodies using a spectrum of microbeads.

R Pei1, J Lee, T Chen, S Rojo, P I Terasaki.   

Abstract

We describe here the use of HLA antigen coated beads for specificity and class determination of HLA antibodies by flow cytometry. The HLA specificity of antibodies was determined by use of beads containing eight levels of fluorescence. HLA antigens isolated from eight cultured cells were coated onto these beads so that each bead was the equivalent of one cell. By using four sets of eight beads, an equivalent of 32 cells could be examined in four test tubes. A total of 76 class I and 25 class II specificities could be determined by the 32 class I bead-panel and 32 class II bead-panel used, respectively. We noted no cross-reactivity of reactions between class I and II. The sensitivity of the test was shown to be higher than that of the standard cytotoxicity by dilution experiments and detection of additional cross-reacting antigens. By use of these coated beads, we achieved improved standardized detection of HLA antibodies. Antigen-coated beads have several advantages over the use of spleens or lymphocytes. (a) A highly selected panel of antigens can be routinely used. (b) Class I and class II antibodies can be readily distinguished from each other, even when they are present as mixtures in one serum. (c) Non-HLA antibodies are not detected because the beads do not have any other antigens than HLA on them. (d) The quantity of antigens coated on beads is more uniform than that found in cells from different individuals. (e) Beads are more convenient for storage and daily use.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626745     DOI: 10.1016/s0198-8859(99)00121-4

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  30 in total

1.  Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.

Authors:  Andrew M Posselt; Gregory L Szot; Lynda A Frassetto; Umesh Masharani; Mehdi Tavakol; Raj Amin; Joan McElroy; Marissa D Ramos; Robert K Kerlan; Lawrence Fong; Flavio Vincenti; Jeffrey A Bluestone; Peter G Stock
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

Review 2.  Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions.

Authors:  David F Stroncek; Emmanuel Fadeyi; Sharon Adams
Journal:  Transfus Med Rev       Date:  2007-10

3.  Analysis of a high-throughput HLA antibody screening assay for use with platelet donors.

Authors:  Emmanuel Fadeyi; Sharon Adams; Brett Peterson; Julia Hackett; Phyllis Byrne; Harvey G Klein; Francesco M Marincola; Susan F Leitman; David F Stroncek
Journal:  Transfusion       Date:  2008-04-15       Impact factor: 3.157

Review 4.  The role of complement in antibody-mediated rejection in kidney transplantation.

Authors:  Mark D Stegall; Marcio F Chedid; Lynn D Cornell
Journal:  Nat Rev Nephrol       Date:  2012-10-02       Impact factor: 28.314

5.  Swine Leukocyte Antigen Class II Is a Xenoantigen.

Authors:  Joseph M Ladowski; Luz M Reyes; Gregory R Martens; James R Butler; Zheng-Yu Wang; Devin E Eckhoff; Matthew Tector; A Joseph Tector
Journal:  Transplantation       Date:  2018-02       Impact factor: 4.939

6.  Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.

Authors:  Dinesh Kannabhiran; John Lee; Joseph E Schwartz; Rex Friedlander; Meredith Aull; Thangamani Muthukumar; Sean Campbell; David Epstein; Surya V Seshan; Sandip Kapur; Vijay K Sharma; Manikkam Suthanthiran; Darshana Dadhania
Journal:  Transplantation       Date:  2015-06       Impact factor: 4.939

Review 7.  Sensitized renal transplant recipients: current protocols and future directions.

Authors:  James Gloor; Mark D Stegall
Journal:  Nat Rev Nephrol       Date:  2010-03-16       Impact factor: 28.314

8.  Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma.

Authors:  Philip J Norris; Jar-How Lee; Danielle M Carrick; Jerome L Gottschall; Mila Lebedeva; B R de Castro; Steven H Kleinman; Michael P Busch
Journal:  Transfusion       Date:  2008-10-29       Impact factor: 3.157

9.  HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.

Authors:  Marianne E McPherson; Alan R Anderson; Marta-Inés Castillejo; Christopher D Hillyer; Robert A Bray; Howard M Gebel; Cassandra D Josephson
Journal:  Pediatr Blood Cancer       Date:  2010-04       Impact factor: 3.167

10.  Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody.

Authors:  Ron Shapiro; Adriana Zeevi; Amit Basu; Henkie P Tan; Liise K Kayler; Deanna M Blisard; Ngoc L Thai; Alin L Girnita; Parmjeet S Randhawa; Edward A Gray; Amadeo Marcos; Thomas E Starzl
Journal:  Transplantation       Date:  2008-04-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.